Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing

Judith Pirngruber, Andrei Shchebet, Steven Johnsen

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

Cyclin-dependent kinase-9 (CDK9) was originally characterized as a transcription elongation factor which regulates RNA Polymerase II (RNAPII) activity following transcriptional initiation. However, recent evidence from a number of studies have shown that CDK9 plays an important role in regulating not only RNAPII activity but also cotranscriptional histone modification and mRNA processing events such as splicing and 3′ end processing. Importantly, our previous work and the work presented here demonstrate that CDK9 functions to guide a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3. This function appears to be dependent upon not only the phosphorylation of the RNA Polymerase II C-terminal domain but also upon other CDK9 targets such as the Suppressor of Ty Homolog-5 (SUPT5H), Negative Elongation Factor-E (NELF-E) and probably the human Rad6 homolog UBE2A. We provide a working model by which CDK9 may control co-transcriptional replication-dependent histone mRNA 3′ end processing in an H2Bub1 and H3K4me3-dependent manner and uncover new and important differences between the functions of human CDK9 and its yeast counterparts Ctk1 and Bur1.

Original languageEnglish (US)
Pages (from-to)3636-3642
Number of pages7
JournalCell Cycle
Volume8
Issue number22
DOIs
StatePublished - Nov 15 2009
Externally publishedYes

Fingerprint

Cyclin-Dependent Kinase 9
Positive Transcriptional Elongation Factor B
Chromatin
Messenger RNA
RNA Polymerase II
Histone Code
RNA Polymerase III
Peptide Elongation Factors
Histones
Lysine
Transcription Factors
Yeasts
Phosphorylation

Keywords

  • Cyclin-dependent kinase
  • Histone modifications
  • Monoubiquitination
  • mRNA processing
  • RNA polymerase II

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Cite this

Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing. / Pirngruber, Judith; Shchebet, Andrei; Johnsen, Steven.

In: Cell Cycle, Vol. 8, No. 22, 15.11.2009, p. 3636-3642.

Research output: Contribution to journalReview article

@article{18447929198f41469ecea1c0d10d7097,
title = "Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing",
abstract = "Cyclin-dependent kinase-9 (CDK9) was originally characterized as a transcription elongation factor which regulates RNA Polymerase II (RNAPII) activity following transcriptional initiation. However, recent evidence from a number of studies have shown that CDK9 plays an important role in regulating not only RNAPII activity but also cotranscriptional histone modification and mRNA processing events such as splicing and 3′ end processing. Importantly, our previous work and the work presented here demonstrate that CDK9 functions to guide a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3. This function appears to be dependent upon not only the phosphorylation of the RNA Polymerase II C-terminal domain but also upon other CDK9 targets such as the Suppressor of Ty Homolog-5 (SUPT5H), Negative Elongation Factor-E (NELF-E) and probably the human Rad6 homolog UBE2A. We provide a working model by which CDK9 may control co-transcriptional replication-dependent histone mRNA 3′ end processing in an H2Bub1 and H3K4me3-dependent manner and uncover new and important differences between the functions of human CDK9 and its yeast counterparts Ctk1 and Bur1.",
keywords = "Cyclin-dependent kinase, Histone modifications, Monoubiquitination, mRNA processing, RNA polymerase II",
author = "Judith Pirngruber and Andrei Shchebet and Steven Johnsen",
year = "2009",
month = "11",
day = "15",
doi = "10.4161/cc.8.22.9890",
language = "English (US)",
volume = "8",
pages = "3636--3642",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "22",

}

TY - JOUR

T1 - Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing

AU - Pirngruber, Judith

AU - Shchebet, Andrei

AU - Johnsen, Steven

PY - 2009/11/15

Y1 - 2009/11/15

N2 - Cyclin-dependent kinase-9 (CDK9) was originally characterized as a transcription elongation factor which regulates RNA Polymerase II (RNAPII) activity following transcriptional initiation. However, recent evidence from a number of studies have shown that CDK9 plays an important role in regulating not only RNAPII activity but also cotranscriptional histone modification and mRNA processing events such as splicing and 3′ end processing. Importantly, our previous work and the work presented here demonstrate that CDK9 functions to guide a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3. This function appears to be dependent upon not only the phosphorylation of the RNA Polymerase II C-terminal domain but also upon other CDK9 targets such as the Suppressor of Ty Homolog-5 (SUPT5H), Negative Elongation Factor-E (NELF-E) and probably the human Rad6 homolog UBE2A. We provide a working model by which CDK9 may control co-transcriptional replication-dependent histone mRNA 3′ end processing in an H2Bub1 and H3K4me3-dependent manner and uncover new and important differences between the functions of human CDK9 and its yeast counterparts Ctk1 and Bur1.

AB - Cyclin-dependent kinase-9 (CDK9) was originally characterized as a transcription elongation factor which regulates RNA Polymerase II (RNAPII) activity following transcriptional initiation. However, recent evidence from a number of studies have shown that CDK9 plays an important role in regulating not only RNAPII activity but also cotranscriptional histone modification and mRNA processing events such as splicing and 3′ end processing. Importantly, our previous work and the work presented here demonstrate that CDK9 functions to guide a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3. This function appears to be dependent upon not only the phosphorylation of the RNA Polymerase II C-terminal domain but also upon other CDK9 targets such as the Suppressor of Ty Homolog-5 (SUPT5H), Negative Elongation Factor-E (NELF-E) and probably the human Rad6 homolog UBE2A. We provide a working model by which CDK9 may control co-transcriptional replication-dependent histone mRNA 3′ end processing in an H2Bub1 and H3K4me3-dependent manner and uncover new and important differences between the functions of human CDK9 and its yeast counterparts Ctk1 and Bur1.

KW - Cyclin-dependent kinase

KW - Histone modifications

KW - Monoubiquitination

KW - mRNA processing

KW - RNA polymerase II

UR - http://www.scopus.com/inward/record.url?scp=70449915963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449915963&partnerID=8YFLogxK

U2 - 10.4161/cc.8.22.9890

DO - 10.4161/cc.8.22.9890

M3 - Review article

C2 - 19844166

AN - SCOPUS:70449915963

VL - 8

SP - 3636

EP - 3642

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 22

ER -